
Xpert MTB/RIF Ultra assay for pulmonary tuberculosis and rifampicin resistance in adults and adolescents
InfectologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- The Cochrane database of systematic reviews
- Publicado em
- 29 jul 2025
- Citações
- 14
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Xpert MTB/RIF Ultra assay for pulmonary tuberculosis and rifampicin resistance in adults and adolescents
David J Horne, Jerry S Zifodya, Adrienne E Shapiro, Elizabeth Chandler Church, Jonah S Kreniske, Alexander W Kay, Katie Scandrett, Karen R Steingart, Yemisi Takwoingi
Descritores MeSH
- Drug Resistance, Bacterial
- Antibiotics, Antitubercular
- Mycobacterium tuberculosis
- Rifampin
- Tuberculosis, Pulmonary
- Bias
- Randomized Controlled Trials as Topic
- Sensitivity and Specificity
- Adult
- Adolescent
Veja também
Estudos relacionados
- Low-complexity automated nucleic acid amplification tests for extrapulmonary tuberculosis and rifampicin resistance in adults and adolescents
- Truenat MTB assays for pulmonary tuberculosis and rifampicin resistance in adults and adolescents
- Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children
- A meta-analysis of the accuracy of Xpert MTB/RIF in diagnosing intestinal tuberculosis